BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases February 6, 2024
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy January 30, 2024
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024 December 6, 2023
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules November 13, 2023
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules November 9, 2023
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care November 2, 2023
